Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-Cov-2 Induced Pulmonary Fibrosis”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)Looking for participantsNCT04541680
What this trial is testing

Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis

Who this might be right for
SARS-Cov-2 Induced Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 250
Post-approval studies (Phase 4)UnknownNCT04856111
What this trial is testing

Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia

Who this might be right for
Novel Coronavirus-induced Lung Fibrosis
Post Graduate Institute of Medical Education and Research, Chandigarh 48

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation